
Shutterstock.com
Dry eye affects one in four people; however, those living with the condition have limited treatment options.
According to research presented at the American Academy of Ophthalmology Annual Meeting (12 November 2017), a team of researchers studied the efficacy of a neurostimulator device for increasing tear production in people with moderate-to-severe dry eye[1]
.
The team showed that, in a one-day crossover study with 48 patients, applying the device intranasally resulted in significantly greater tear production (25.3mm/min) compared with both a placebo device (9.2mm/min) and applying the device extranasally (9.5 mm/min).
The researchers followed 97 patients who used the device over 180 days, finding significantly greater tear production following neurostimulation than previously (17.3mm/min vs 7.9 mm/min).
No serious device-related adverse events were reported.
The team said the results indicated that the neurostimulation technology increased acute and long-term tear production in dry eye.
References
[1] Holland E, Baba S, Senchyna M et al. Intranasal tear neurostimulation for subjects with dry eye disease: results from 2 pivotal clinical trials. 121st Annual Meeting of the American Academy of Ophthalmology, New Orleans, Louisiana, 11–14 November 2017
You may also be interested in

More than 17,000 consultations delivered under independent prescribing pathfinder service
